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Abstract
Background Alcohol septal ablation (ASA) provides symp-
tomatic relief in most but not all patients with hypertrophic
obstructive cardiomyopathy (HOCM). Therefore we inves-
tigated predictors of outcome after ASA.
Methods Clinical, echocardiographic, angiographic and pro-
cedural characteristics were analysed in 113 consecutive
patients. Successful ASA was defined as NYHA≤2 with
improvement of at least 1 class combined with a resting
gradient<30 mmHg and provoked gradient<50 mmHg at
4-month follow-up.
Results In 37 patients ASAwas not successful. In multivar-
iate analysis, baseline gradient (OR 1.06 (1.01–1.11) per
5 mmHg, p=0.024) and distance to the ablated septal branch
(OR 1.09 (1.03–1.16) per mm, p=0.004) were predictors of
unsuccessful outcome. The combined presence of a non-
ablated septal branch and a distance≥19 mm to the ablated
branch was a predictor of unsuccessful outcome (OR 5.88
(2.06–16.7), p<0.001).
Conclusions Baseline gradient and a greater distance from
the origin of the left anterior descending artery to the ablated
septal branch combined with a non-ablated proximal septal
branch are associated with an unsuccessful outcome after
ASA.
Keywords Hypertrophic obstructive cardiomyopathy . Left
ventricularoutflowtract .Alcohol septal ablation .Outcome .
Septal anatomy
Introduction
In patients with symptomatic hypertrophic obstructive car-
diomyopathy (HOCM), percutaneous alcohol septal ablation
(ASA) is an accepted alternative to surgical septal myectomy
(‘myectomy’) [1–3]. Although no randomised controlled
trials have been performed, observational meta-analyses for
ASA versus myectomy show excellent long-term survival
rates for both procedures [4–7]. However, reduction of the
gradient in the left ventricular outflow tract (LVOT) appears
to be slightly less for patients who undergo ASA [4]; repeat
interventions are performed more often after ASA [8] and in
a single-centre study cardiac death occurred more often after
ASA compared with myectomy [9]. With myectomy, the
basal part of the septum, responsible for the obstruction of
the LVOT, is usually resected completely. In contrast, after
ASA the most basal part of the septum may in some cases be
spared causing residual obstruction [10]. In this study, we
studied the predictors of outcome after ASA with special
interest for the septal coronary anatomy.
Methods
Patients
We studied patients who were treated for HOCM at the St.
Antonius Hospital in Nieuwegein, the Netherlands. For pa-
tients to be selected for septum reduction (either ASA or
myectomy) they had to have severe symptoms (New York
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Heart Association functional class≥3) despite trial of opti-
mal medical therapy in combination with a resting gradient
in the left ventricular outflow tract (LVOT)≥30 mmHg
and/or a provocable gradient≥50 mmHg. All patients were
required to have left ventricular asymmetrical septal hyper-
trophy, with a minimal septum diameter≥15 mm. Patients
with concomitant (sub)valvular disease or other conditions
that warranted surgery were accepted to undergo surgical
myectomy. Patients who were eligible for both options were
informed about the known risks and benefits of both ASA
and surgical myectomy and were offered the choice between
these procedures. Routine clinical and echocardiographic
assessments were performed in all patients. We performed
a retrospective analysis of all the clinical data along with
analysis of the echocardiographic images and coronary an-
giograms. Civil registries were used to determine survival in
January 2011. The study conformed to principles defined in
the Helsinki Declaration.
Definitions
Successful symptomatic relief was defined as a New York
Heart Association (NYHA) functional class≤2 with a low-
ering of at least one NYHA class at follow-up. The combi-
nation of both successful symptomatic relief with a resting
gradient<30 mmHg and a provoked gradient<50 mmHg
during echocardiographic assessment at 4-month follow-up
was used as a strict definition for successful outcome.
Alcohol septal ablation
ASAwas performed as described in detail previously [11]. In
short, with the aid of a flexible coronary guide wire, a
coronary balloon was placed in the most proximal septal
branch. Myocardial contrast echocardiography was used
for further guidance. When the region of contrast in the
septum was satisfactory and adjacent to the area of septal
contact of the anterior mitral valve leaflet, 0.5 to 3 ml of
concentrated ethanol was slowly injected through the inflat-
ed balloon catheter. The balloon was left inflated for 10 min
to prevent retrograde spill of ethanol. Invasive gradients in
the LVOTwere measured continuously during the procedure
using a 6 French pigtail catheter inserted in the left ventricle.
For testing of a provocable gradient, the Valsalva manoeuvre
and extrasystolic beats were used. When the gradient in the
LVOT remained≥30 mmHg after the first ablation (either at
rest or after provocation), the procedure was repeated in a
second septal branch. During the procedure, all patients
received a temporary transvenous pacemaker. If an AV block
remained more than 48 h after the procedure, a definitive
pacemaker was implanted.
Echocardiography
All echocardiograms were performed with Hewlett-Packard
Sonos 5500 and Philips IE33 ultrasound imaging systems
and were stored as digital images in a database. Philips’
Excelera software program was used for all measurements,
which were performed by a single observer (RCS) who was
blinded for the purpose of the study. Measurement of the
peak LVOT gradient both at rest and after provocation using
the Valsava manoeuvre was obtained in the apical 3 or 5
chamber view. The degree of mitral insufficiency (MI) was
graded from 0 to 4 (grade 0=no MI, grade 1=mild, grades 2
and 3=moderate, grade 4=severe) [12]. The degree of sys-
tolic anterior motion (SAM) was graded from 0 to 4 (grade
0=no SAM, grade 1=SAM with distance from septum to
AMVL>10 mm, grade 2=SAM with distance from septum
to AMVL<10 mm, grade 3=AMVL makes brief septal
contact, grade 4=septal contact>30 % during systole) [13].
The minimal LVOT diameter was measured as the narrowest
part in the LVOT between the septum and the basis of the
anterior mitral valve leaflet (AMVL) during systole. At
4 months of follow-up after ASA, the baseline measurements
were repeated and in addition, in the parasternal long-axis
view, septal thinning due to the infarction was evaluated
at end-diastole. When septal thinning was found from the
beginning of the septum, the infarction was considered to
be without sparing of the basal septum. Otherwise, the
infarction was considered to have spared the basal septum.
Akinesia of the basal septum was rated as either present
or absent.
Coronary angiography
Coronary angiography was usually performed shortly before
the procedure. For the purpose of the present study, the
coronary angiograms of all patients were retrospectively
analysed for the presence of non-ablated proximal septal
branches. All branches that clearly perfused the septum and
were proximal to the first ablated septal branch were consid-
ered non-ablated septal branches. Furthermore, using Philips
suite QCA with the catheter diameter for calibration, we
measured the distance from the origin of the LAD to the
origin of the ablated septal branch. We also measured the
diameters of the origin of both the non-ablated proximal
septal branch and the ablated septal branches.
Statistical analysis
Data are given as the mean and standard deviation when
normally distributed, as the median with interquartile range
for skewed distributions, and as frequencies and percentages
for categorical variables. The Student’s t-test was used for
continuous variables and the chi-square test was used to
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compare categorical variables. Pearson’s test was used for
calculating correlations. Logistic regression was carried out
to identify univariate predictors of unsuccessful outcome.
Stepwise backward logistic regression analysis was carried
out in a multivariate analysis. Variables were considered in
the multivariate models when a P-value of<0.1 was obtained
in the univariate analysis. In secondary analysis, interaction
analysis was carried out to establish significant interactions
between the variables of septal coronary anatomy and unsuc-
cessful outcome. All reported probability values are two-
tailed, a P-value<0.05 was considered statistically significant
and a P-value<0.1 was considered significant for interaction
analysis. Statistical analyses were performed using STATA,
College Station, Texas, version 10.0.
Results
A dataset of 113 patients who underwent ASA in our insti-
tution from January 2000 to December 2009 was completed.
At 4-month follow-up a successful symptomatic result was
found in 90 % of all patients. The total group showed
reduction of the echocardiographic gradient both at rest and
after provocation from 50 mmHg±43 and 113 mmHg±61,
respectively, before the procedure to 22 mmHg±26 and
38 mmHg±40, measured 4 months after ASA (p<0.001).
According to the definition of the present study, ASA was
successful in 76 patients (successful group) and unsuccessful
in 37 patients (unsuccessful group). The baseline characteris-
tics of the patients in the two groups did not differ significantly
(Table 1). At 4 months after the procedure, the NYHA func-
tional class had improved, resulting in a post-procedural
NYHA functional class of 1.0±0.6 in the successful group
versus 1.9±1.0 in the unsuccessful group (p<0.001).
In terms of peri-procedural complications ventricular fibril-
lation occurred once and was treated with defibrillation,
tamponade occurred once and was treated with pericar-
diocentesis and dissection in the LAD occurred once and was
treated with a stent implantation. A definitive pacemaker was
inserted in five patients. During a follow-up of 5.3±2.5 years
there were 4 deaths (3 non-cardiac, 1 cardiac), amounting an
annual all-cause mortality of 0.7 %.
Echocardiographic findings
Echocardiographic findings at baseline and at 4-month
follow-up comparing both groups are shown in Table 2.
Before ASA, the resting gradient in the LVOT was higher
in the unsuccessful group than in the successful group, but
the other characteristics were comparable. Inherent to the
definition of successful outcome, after ASA the LVOT gradi-
ent in the unsuccessful group was higher than in the successful
group. Furthermore, in the unsuccessful group, infarctions
with sparing of the basal septum were more common than
in the successful group. Of note, infarctions without sparing
of the basal septum were associated with a larger minimal
Table 1 Baseline characteristics
Data are presented as mean ±
standard deviation or as percent-
age (number)
ASA alcohol septal ablation, CCS
Canadian Cardiovascular Society,
CK creatine kinase, NYHA New
York Heart Association
Variables Outcome after ASA P-value
Successful (n=76) Unsuccessful (n=37)
Age (years) 56±17 57±14 0.93
Male sex (% (n)) 55 (41) 44 (17) 0.32
NYHA functional class 2.9±0.4 2.8±0.7 0.78
Angina functional class 1.9±0.4 2.0±0.4 0.33
Syncope (% (n)) 23 (17) 18 (7) 0.71
β-blocker or Ca-blocker (% (n)) 83 (63) 78 (29) 0.52
Previous pacemaker (% (n)) 5 (4) 0 (0) 0.36
Max CK (U/l) 1294±461 1431±793 0.34
Max CK Mb (U/l) 201±124 167±59 0.051
Hospital stay, days 5.6±4 6.3±5 0.49
Angiographic findings
- Non-ablated branch present (% (n)) 26 (19) 50 (19) 0.01
- Distance to ablated branch (mm) 16±7 20±8 0.006
- Diameter ablated branch (mm) 1.7±0.4 1.6±0.5 0.25
- Diameter non-ablated branch (mm) 1.0±0.3 1.1±0.4 0.32
- Amount of alcohol (ml) 2.4±0.7 2.3±0.5 0.55
- Number of ablated branches 1.2±0.4 1.2±0.4 0.99
- Invasive gradient pre ASA (mmHg) 83±32 95±35 0.08
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LVOT (20±4 vs 15±4, p<0.001) and a lower grade of SAM
(0.7±0.6 vs 2.0±1.1, p<0.001) compared with infarctions
with sparing.
Angiographic findings
The angiographic findings are shown in Table 1. In the
unsuccessful group, there were more patients with a non-
ablated proximal septal branch and the distance from the
origin of the LAD to the ablated branch was greater. In both
groups the diameter of the first ablated branch was larger
than the diameter of the non-ablated proximal septal branch
(p<0.01 for both groups).
Predictors of unsuccessful outcome
Of all the clinical and echocardiographic characteristics at
baseline, only baseline resting gradient at echocardiography
predicted outcome. Of the angiographic characteristics, both
the presence of a non-ablated proximal septal branch and the
distance to the ablated septal branch were predictors of
outcome (Table 3). After multivariate analysis, only the
distance to the ablated branch and baseline resting gradient
were found to be predictive for outcome after ASA (Table 3).
Secondary analysis revealed a significant interaction be-
tween the distance to the ablated branch and the presence
of a nonablated proximal septal branch when the distance
was dichotomised based on the 19 mm optimal cut-off point
(using highest sensitivity and specificity) (P-value for inter-
action 0.025). The presence of a non-ablated proximal septal
branch and a distance≥19 mm to the ablated branch predicted
an unsuccessful outcome (OR 5.88 (2.06–16.74), P<0.001),
Table 4) Of note, in this subgroup of patients (n=27/113,
24 %), sparing of the basal septum was more common
(55 % versus 15 %, p<0.001) compared with the other
patients.
Discussion
Symptomatic relief was found in 90 % of patients, compa-
rable with previous results [1, 14], but success of ASA in
terms of reduction of the gradient was somewhat less com-
mon. We found that a greater distance from the origin of the
Table 2 Echocardiographic
findings at baseline and 4 months
follow up
Data are presented as mean ±
standard deviation or as percent-
age (number)
LVOT left ventricular outflow
tract, MI Mitral insufficiency,
SAM systolic anterior motion
Variables Outcome after ASA P value
Baseline Successful (n=76) Unsuccessful (n=37)
Septal thickness (mm) 22±5 22±5 0.95
Posterior wall thickness (mm) 15±3 16±3 0.71
End-diastolic volume (ml) 77±25 74±26 0.63
End-systolic volume (ml) 18±11 16±7 0.20
Ejection fraction (%) 76±? 78±? 0.41
LVOT min (mm) 14±5 13±5 0.66
Degree of MI 1.5±1.0 1.7±1.1 0.50
Degree of SAM 2.9±0.6 3.0±0.6 0.14
Resting gradient (mmHg) 43±40 63±46 0.026
Provoked gradient (mmHg) 107±53 126±67 0.15
At 4-month follow-up
Septal thickness (mm) 20±4 20±4 0.43
Posterior wall thickness (mm) 14±3 14±3 0.62
End-diastolic volume (ml) 81±27 74±24 0.14
End-systolic volume (ml) 23±15 18±9 0.053
Ejection fraction (%) 74±10 77±10 0.16
LVOT min (mm) 19±4 15±5 <0.001
LVOT min, increase 5.6±4 1.7 ±3 <0.001
Degree of MI 0.5±0.7 1.0±1.0 0.020
Degree of SAM 1.0±0.9 2.2±1.1 <0.001
Akinetic basal septum (% (n)) 72 (55) 19 (7) <0.001
Without sparing basal septum (% (n)) 58 (45) 17 (6) <0.001
Resting gradient (mmHg) 12±7 41±38 <0.001
Provoked gradient (mmHg) 17±10 91±53 <0.001
Decrease provoked gradient (mmHg) 91±53 35±60 <0.001
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LAD to the ablated septal branch, especially in the presence
of a non-ablated proximal septal branch, was associated with
an unsuccessful outcome 4 months after ASA, independent
of the severity of the baseline resting gradient. In terms
of safety, mortality rate was low. Complication rates in
our study were low including the number of pacemaker
implantations, probably due to the low amounts of alcohol we
used based on careful assessment with myocardial contrast
echocardiography.
Unfavourable coronary anatomy
As previously demonstrated using cardiac MRI, patients
exhibit a more variable location of septal thinning after
ASA compared with surgical myectomy [10]. The access to
the perfusion bed of the most basal part of the septum may
for the interventional cardiologist be limited or difficult due
to the variability of the septal anatomy [15–17]. Even though
ASA was only performed after contrast was seen in the
region of interest using myocardial contrast echocardiogra-
phy, we also found a considerable variation of the location of
the infarction in our study. Moreover, an unfavourable anat-
omy (combined presence of a non-ablated proximal septal
branch and a distance≥19 mm to the ablated branch) was
associated with an unsuccessful outcome. In these patients
more frequent sparing of the most basal septum was found
accompanied by a smaller minimal LVOT diameter and a
higher grade of SAM. This may explain a lower success rate
of ASA in patients with an unfavourable anatomy. For these
patients, surgical myectomy might thus be a preferred method
instead of ASA. The effect of an unfavourable anatomy on
long-term survival and clinical outcomewarrants further study.
Limitations
This was a retrospective single-centre study. Measurements
were performed on the available angiographic images but we
cannot rule out that more targeted imaging might have
yielded more anatomically correct values. We used a strict
definition for success consisting of a combined symptomatic
result with the same haemodynamic criteria for invasive
treatment mentioned in current guidelines [18]; however,
there is no clear consensus for definition of success after
ablation. The choice of the endpoint at 4 months was a
practical one, simply based on the first contact at the outpa-
tient clinic. It cannot be excluded that further improvements
in symptomatic status and LVOT gradients occurred beyond
4 months after ASA.
Table 3 Univariate and multivariate predictors of unsuccessful outcome
Variable Univariate Multivariate
OR (95 % CI) P-value OR (95 % CI) P-value
Age 1.00 (0.97–1.03) 0.87
Sex (males) 1.50 (0.68–3.32) 0.32
Baseline resting gradient (per 5 mmHg) 1.06 (1.01–1.11) 0.024 1.06 (1.01–1.11) 0.024
Distance to ablated branch (per mm) 1.08 (1.03–1.55) 0.005 1.09 (1.03–1.16) 0.004
Non-ablated branch present 2.85 (1.24–6.53) 0.013
OR odds ratio
Table 4 Multivariate predictors of successful outcome taking into account the interaction between the distance to the ablated branch and the
presence of a non-ablated branch
Variable N Univariate Mulitvariate
OR (95 % CI) P-value OR (95 % CI) P-value
Baseline resting gradient (per 5 mmHg) 1.06 (1.01–1.11) 0.024 1.05 (1.00–1.10) 0.061
Distance vs non-ablated branch
- Distance<19 mm, non-ablated branch not present 54 1.00 – 1.00 –
- Distance≥19 mm, non-ablated branch not present 21 0.99 (0.30–3.21) 0.98 1.14 (0.33–3.88) 0.83
- Distance<19 mm, non-ablated branch present 11 0.32 (0.36–2.70) 0.29 0.40 (0.05–3.52) 0.41
- Distance≥19 mm, non-ablated branch present 27 5.36 (1.97–14.57) 0.001 5.88 (2.06–16.74) 0.001
OR odds ratio
Distance: the measured distance from the origin of the LAD to the origin of the ablated septal branch
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Conclusions
Baseline gradient and the combined presence of a non-
ablated proximal of septal branch with a greater distance to
the ablated septal branch was found to be associated with an
unsuccessful outcome after ASA. In practical terms this
implies that ASA should probably not be performed when
septal anatomy is unfavourable.
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